These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15780066)

  • 1. Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites.
    Ahloulay M; Bankir L; Lugnier C; Le Bec A; Poirel O; Moreau R; Lebrec D
    Liver Int; 2005 Apr; 25(2):403-9. PubMed ID: 15780066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
    Angeli P; Jiménez W; Veggian R; Fasolato S; Volpin R; MacHenzie HS; Craighero R; Libera VD; Sticca A; Arroyo V; Gatta A
    Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs.
    Tanahashi M; Hara S; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1533-8. PubMed ID: 10336549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific type IV phosphodiesterase inhibitor ameliorates cerulein-induced pancreatitis in rats.
    Sato T; Otaka M; Odashima M; Kato S; Jin M; Konishi N; Matsuhashi T; Watanabe S
    Biochem Biophys Res Commun; 2006 Jul; 346(1):339-44. PubMed ID: 16759642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of renal ecto-phosphodiesterase.
    Jackson EK; Ren J; Zacharia LC; Mi Z
    J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors.
    Uckert S; Bazrafshan S; Scheller F; Mayer ME; Jonas U; Stief CG
    Urology; 2007 Jul; 70(1):185-9. PubMed ID: 17656245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of a novel, orally active PDE4 inhibitor.
    Dastidar SG; Ray A; Shirumalla R; Rajagopal D; Chaudhary S; Nanda K; Sharma P; Seth MK; Balachandran S; Gupta N; Palle V
    Pharmacology; 2009; 83(5):275-86. PubMed ID: 19321962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats.
    Yu HP; Hsieh PW; Chang YJ; Chung PJ; Kuo LM; Hwang TL
    Biochem Pharmacol; 2009 Oct; 78(8):983-92. PubMed ID: 19540209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
    Núñez C; González-Cuello A; Sánchez L; Vargas ML; Milanés MV; Laorden ML
    Eur J Pharmacol; 2009 Oct; 620(1-3):1-8. PubMed ID: 19683523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection.
    Erdogan S; Aslantas O; Celik S; Atik E
    Res Vet Sci; 2008 Feb; 84(1):18-25. PubMed ID: 17397885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.
    Kalambokis G; Fotopoulos A; Economou M; Pappas K; Tsianos EV
    J Hepatol; 2007 Feb; 46(2):213-21. PubMed ID: 17156883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an experimental model of induced bacterial peritonitis in cirrhotic rats with or without ascites.
    Sánchez E; Such J; Chiva MT; Soriano G; Llovet T; Mercè J; Sancho F; Muñoz C; Song XY; Pérez-Mateo M; Balanzó J; Guarner C
    Am J Gastroenterol; 2007 Jun; 102(6):1230-6. PubMed ID: 17531011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat.
    Ghali-Ghoul R; Tahseldar-Roumieh R; Sabra R
    Eur J Pharmacol; 2007 Oct; 572(1):49-56. PubMed ID: 17610866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.
    Videla S; Vilaseca J; Medina C; Mourelle M; Guarner F; Salas A; Malagelada JR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):940-5. PubMed ID: 16254133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
    Levy M
    Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.